"Health care leader whose mission is to keep you healthy. Under-one-roof convenience, 24-hour advice nurse, and online access to manage your health anytime. We are here to care for you virtually or in-person. Start by connecting with your care team online (visit our website) or by calling the Appointment and Advice Contact Center at 303-338-4545 or 1-800-218-1059 (TTY 711)."

During the past decade, Kaiser Permanente-Rock Creek conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 45 clinical trials were completed, i.e. on average, 104.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 22 clinical trials were completed. i.e. 314.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kaiser Permanente-Rock Creek" #1 sponsor was "National Cancer Institute (NCI)" with 50 trials, followed by "SWOG Cancer Research Network" with 17 trials sponsored, "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "NSABP Foundation Inc" with 6 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente-Rock Creek" #1 collaborator was "National Cancer Institute (NCI)" with 39 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Kaiser Permanente-Rock Creek" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Breast Cancer" (6 trials), "Recurrent Breast Carcinoma" (5 trials) and "Fallopian Tube Transitional Cell Carcinoma" (4 trials). Many other conditions were trialed in "Kaiser Permanente-Rock Creek" in a lesser frequency.

Most popular intervention types in "Kaiser Permanente-Rock Creek" are "Drug" (73 trials), "Other" (69 trials), "Biological" (47 trials), "Procedure" (22 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (37 trials), "Quality-of-Life Assessment" (31 trials), "Computed Tomography" (17 trials), "Biospecimen Collection" (16 trials) and "Questionnaire Administration" (16 trials). Other intervention names were less common.

The vast majority of trials in "Kaiser Permanente-Rock Creek" are 78 trials for "All" genders and 18 trials for "Female" genders.

Currently, there are NaN active trials in "Kaiser Permanente-Rock Creek". undefined are not yet recruiting, 14 are recruiting, 46 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Kaiser Permanente-Rock Creek, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Kaiser Permanente-Rock Creek, 0 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 67 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".